Top

International Journal of Colorectal Disease

Published in:

01-11-2011 | Original Article

Migration and chemokine receptor pattern of colitis-preventing DX5⁺NKT cells

Authors: Matthias Hornung, Jens M. Werner, Stefan Farkas, Hans J. Schlitt, Edward K. Geissler

Published in: International Journal of Colorectal Disease | Issue 11/2011

Abstract

Purpose

DX5⁺NKT cells are a subpopulation of NKT cells expressing both T cell receptor and NK cell markers that show an immune-regulating function. Transferred DX5⁺NKT cells from immune competent Balb/c mice can prevent or reduce induced colitis in severe combined immunodeficient (SCID) mice. Here, we investigated the in vivo migration of DX5⁺NKT cells and their corresponding chemokine receptor patterns.

Methods

DX5⁺NKT cells were isolated from spleens of Balb/c mice and transferred into Balb/c SCID mice. After 2 and 8 days, in vivo migration was examined using in vivo microscopy. In addition, the chemokine receptor pattern was analyzed with fluorescence-activated cell sorting (FACS) and the migration assay was performed.

Results

Our results show that labeled DX5⁺NKT cells were primarily detectable in mesenteric lymph nodes and spleen after transfer. After 8 days, DX5⁺NKT cells were observed in the colonic tissues, especially the appendix. FACS analysis of chemokine receptors in DX5⁺NKT cells revealed expression of CCR3, CCR6, CCR9, CXCR3, CXCR4, and CXCR6, but no CCR5, CXCR5, or the lymphoid homing receptor CCR7. Stimulation upregulated especially CCR7 expression, and chemokine receptor patterns were different between splenic and liver DX5⁺NKT cells.

Conclusions

These data indicate that colitis-preventing DX5⁺NKT cells need to traffic through lymphoid organs to execute their immunological function at the site of inflammation. Furthermore, DX5⁺NKT cells express a specific chemokine receptor pattern with an upregulation of the lymphoid homing receptor CCR7 after activation.

Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M (1995) Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol 7:1157–1161PubMedCrossRef

Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15:535–562PubMedCrossRef

Brossay L, Jullien D, Cardell S, Sydora BC, Burdin N, Modlin RL, Kronenberg M (1997) Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 159:1216–1224PubMed

Somnay-Wadgaonkar K, Nusrat A, Kim HS, Canchis WP, Balk SP, Colgan SP, Blumberg RS (1999) Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol 11:383–392PubMedCrossRef

Burdin N, Kronenberg M (1999) CD1-mediated immune responses to glycolipids. Curr Opin Immunol 11:326–331PubMedCrossRef

Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817–890PubMedCrossRef

Burdin N, Brossay L, Degano M, Iijima H, Gui M, Wilson IA, Kronenberg M (2000) Structural requirements for antigen presentation by mouse CD1. Proc Natl Acad Sci USA 97:10156–10161PubMedCrossRef

Kawano T, Tanaka Y, Shimizu E, Kaneko Y, Kamata N, Sato H, Osada H, Sekiya S, Nakayama T, Taniguchi M (1999) A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. Int Immunol 11:881–887PubMedCrossRef

Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR (1998) Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279:1541–1544PubMedCrossRef

10.

Benlagha K, Bendelac A (2000) CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. Semin Immunol 12:537–542PubMedCrossRef

11.

Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623–1626PubMedCrossRef

12.

Saubermann LJ, Beck P, De Jong YP, Pitman RS, Ryan MS, Kim HS, Exley M, Snapper S, Balk SP, Hagen SJ, Kanauchi O, Motoki K, Sakai T, Terhorst C, Koezuka Y, Podolsky DK, Blumberg RS (2000) Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119:119–128PubMedCrossRef

13.

Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194:1801–1811PubMedCrossRef

14.

Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194:1789–1799PubMedCrossRef

15.

Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 7:1057–1062PubMedCrossRef

16.

Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L (2001) The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 7:1052–1056PubMedCrossRef

17.

Sonoda KH, Taniguchi M, Stein-Streilein J (2002) Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 168:2028–2034PubMed

18.

Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W (2002) Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17:629–638PubMedCrossRef

19.

Hornung M, Farkas SA, Sattler C, Schlitt HJ, Geissler EK (2006) DX5+ NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1. Eur J Immunol 36:1210–1221PubMedCrossRef

20.

Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180:1097–1106PubMedCrossRef

21.

Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what’s in a name? Nat Rev Immunol 4:231–237PubMedCrossRef

22.

Exley M, Garcia J, Balk SP, Porcelli S (1997) Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 186:109–120PubMedCrossRef

23.

Arase H, Saito T, Phillips JH, Lanier LL (2001) Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 167:1141–1144PubMed

24.

Moodycliffe AM, Maiti S, Ullrich SE (1999) Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation. J Immunol 162:5156–5163PubMed

25.

Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE (2000) Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 1:521–525PubMedCrossRef

26.

Osada T, Nagawa H, Shibata Y (2004) Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor. J Immune Based Ther Vaccines 2:7PubMedCrossRef

27.

Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S (2001) Predominance of NK1.1 + TCR alpha beta + or DX5 + TCR alpha beta + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: “natural suppressor” cells. J Immunol 167:2087–2096PubMed

28.

Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, Strober S (2002) Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 169:5564–5570PubMed

29.

Lan F, Zeng D, Higuchi M, Higgins JP, Strober S (2003) Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transplant 9:355–363PubMedCrossRef

30.

Margalit M, Ilan Y, Ohana M, Safadi R, Alper R, Sherman Y, Doviner V, Rabbani E, Engelhardt D, Nagler A (2005) Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes. Bone Marrow Transplant 35:191–197PubMedCrossRef

31.

Yang Y, Ueno A, Bao M, Wang Z, Im JS, Porcelli S, Yoon JW (2003) Control of NKT cell differentiation by tissue-specific microenvironments. J Immunol 171:5913–5920PubMed

32.

Pellicci DG, Hammond KJ, Coquet J, Kyparissoudis K, Brooks AG, Kedzierska K, Keating R, Turner S, Berzins S, Smyth MJ, Godfrey DI (2005) DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J Immunol 175:4416–4425PubMed

33.

Liu L, Callahan MK, Huang D, Ransohoff RM (2005) Chemokine receptor CXCR3: an unexpected enigma. Curr Top Dev Biol 68:149–181PubMedCrossRef

34.

Wallace PK, Palmer LD, Perry-Lalley D, Bolton ES, Alexander RB, Horan PK, Yang JC, Muirhead KA (1993) Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Cancer Res 53:2358–2367PubMed

35.

Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC (1998) 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 141:1053–1059PubMedCrossRef

36.

Johnston B, Kim CH, Soler D, Emoto M, Butcher EC (2003) Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 171:2960–2969PubMed

37.

Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297–336PubMedCrossRef

38.

Bono MR, Elgueta R, Sauma D, Pino K, Osorio F, Michea P, Fierro A, Rosemblatt M (2007) The essential role of chemokines in the selective regulation of lymphocyte homing. Cytokine Growth Factor Rev 18:33–43PubMedCrossRef

39.

Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, Wilson SB, Luster AD (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 171:2571–2580PubMed

40.

Farkas SA, Hornung M, Sattler C, Steinbauer M, Anthuber M, Obermeier F, Herfarth H, Schlitt HJ, Geissler EK (2005) Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis. Eur Surg Res 37:115–122PubMedCrossRef

41.

Singh UP, Venkataraman C, Singh R, Lillard JW Jr (2007) CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets 7:111–123PubMedCrossRef

42.

Lacotte S, Brun S, Muller S, Dumortier H (2009) CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci 1173:310–317PubMedCrossRef

43.

Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, Dustin ML, Littman DR (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3:e113PubMedCrossRef

44.

Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M, Kita T, Taniguchi M, Matsushima K, Yonehara S (2007) Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 179:8172–8179PubMed

45.

Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B (2008) Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 181:81–91PubMed

46.

Nishimura M, Kuboi Y, Muramoto K, Kawano T, Imai T (2009) Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann N Y Acad Sci 1173:350–356PubMedCrossRef

47.

Ransohoff RM (2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31:711–721PubMedCrossRef

48.

Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR, Cyster JG (2002) Chemokine requirements for B cell entry to lymph nodes and Peyer’s patches. J Exp Med 196:65–75PubMedCrossRef

49.

Cupedo T, Lund FE, Ngo VN, Randall TD, Jansen W, Greuter MJ, Waal-Malefyt R, Kraal G, Cyster JG, Mebius RE (2004) Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13. J Immunol 173:4889–4896PubMed

50.

Hayasaka H, Taniguchi K, Fukai S, Miyasaka M (2010) Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking. Cancer Sci 101:2302–2308PubMedCrossRef

51.

Le Y, Zhou Y, Iribarren P, Wang J (2004) Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell Mol Immunol 1:95–104PubMed

Title: Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells
Authors: Matthias Hornung
Jens M. Werner
Stefan Farkas
Hans J. Schlitt
Edward K. Geissler
Publication date: 01-11-2011
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 11/2011
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-011-1249-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Migration and chemokine receptor pattern of colitis-preventing DX5⁺NKT cells

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2011

Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population

Laparoscopic fistula excision and omentoplasty for high rectovaginal fistulas: a prospective study of 40 patients

STARR and the older surgeon: what makes the difference?

Seton drainage in high anal fistula

Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients

Morphological alterations of the enteric nervous system in young male patients with rectal prolapse